EnWave Signs Technology Evaluation and License Option Agreement with Calbee Incorporated

Pharmaceutical Investing

EnWave (TSXV:ENW) has announced that it has signed a technology evaluation and license option agreement with Calbee, a snack food manufacturer in Japan. As quoted in the press release: After multiple site visits and extensive preliminary trials at EnWave’s facilities in Canada, Calbee decided to enter a TELOA to exclusively evaluate several snack food applications …

EnWave (TSXV:ENW) has announced that it has signed a technology evaluation and license option agreement with Calbee, a snack food manufacturer in Japan.
As quoted in the press release:

After multiple site visits and extensive preliminary trials at EnWave’s facilities in Canada, Calbee decided to enter a TELOA to exclusively evaluate several snack food applications at their facilities using lab-scale Radiant Energy Vacuum (“REV™”) technology.
This is the first TELOA signed by EnWave with a Japanese food manufacturing company and represents an important milestone for the Company. Over the past year, EnWave has been working under a Cooperation Agreement with Correns Corporation (“Correns”) of Tokyo to broaden its sales and business development network in Japan. Correns will continue to collaborate with EnWave to support both research and development, as well as potential future commercial installations in Japan.

Click here to read the full press release.

business development canada enwave japan manufacturing trials Pharmaceutical Investing